This Solicitation opportunity from Government of Canada was posted on May 6, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

PRÉPARATION EN LOT DE SERINGUES DE PIPÉRACILLINE-TAZOBACTAM (ANTIBIOTIQUE)

Closed

20132277Canada

Submission Closed06/03/2026, 01:15:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

ENROFLOXACIN TABLETThe contract is for the procurement of enrofloxacin tablets under the National Stock Number 6509-01-487-5834, with a single unit requested through Purchase Request 7017357334. The solicitation, identified as SPE2DP-26-T-3953, was posted on June 30, 2026, and responses are due by July 6, 2026. This procurement is managed by the Defense Logistics Agency under the Department of Defense and is classified as a federal solicitation without any specific set-aside designation. The enrofloxacin tablets are intended for use within federal medical or veterinary systems, though the exact application is not specified. The place of performance and point of contact details are not provided, and all communications and submissions must be directed via the designated DIBBS platform, accessible through the provided UI link. The contract is open for bid under standard federal procurement procedures with no geographical restrictions stated.

Defense Logistics Agency

POSTED

DEADLINE

VACCINES & ETC..., "MERCK ANIMAL HEALTH"The City of Los Angeles has issued a solicitation for vaccines and related products supplied by Merck Animal Health, identified under solicitation number 230776. The opportunity is open for bidding through the City’s Vendor Self Service Website, with bids due by July 8, 2026, at 6:00 PM Pacific Time, following a posting date of June 30, 2026. The solicitation falls under NAICS code 325412, which pertains to pharmaceutical preparation manufacturing, and is classified under SLED governance, indicating it is for state, local, or educational entities. Performance of the contract is expected to occur within Los Angeles, California. inquiries should be directed to Sandy Ke, the designated point of contact, reachable via email at sandy.ke@lacity.org or by phone at 213-928-9547. Interested vendors must access the opportunity through the provided URL, either by logging in or selecting public access to review full details and submit responses. There is no specified set-aside for small, minority-owned, or other specialized business categories.

POSTED

DEADLINE

Lisdexamfetamine Dimesylate Capsules SolicitationThe solicitation for Lisdexamfetamine Dimesylate Capsules, identified by number SPE2D2-26-R-0004, is issued by the Defense Logistics Agency Troop Support under the Department of Defense with a NAICS code of 325412 for pharmaceutical manufacturing. The contract seeks bids for five strengths of lisdexamfetamine capsules—10 MG, 20 MG, 30 MG, 40 MG, 50 MG, 60 MG, and 70 MG—each available in two package sizes: 90-count and 100-count bottles, totaling fourteen line items. All offerings must meet stringent packaging and labeling requirements, including cylindrical bottles of at least 100cc volume with a child-proof safety cap, no glass construction, and compatibility with automated dispensing systems such as OptiFill and Baxter ATC Canisters. Labels must be sized at 5.25” x 2” with an additional 0.5” for bar code visibility, and all bar codes must adhere to GS1-128 or HIBC standards, be grade C or better, and include lot number and expiration date without interfering with the NDC code. The product must be sourced from FDA-approved NDA or ANDA holders, with full disclosure of the country of origin for both the final product and its active pharmaceutical ingredient under the Trade Agreements Act. Offers must be submitted exclusively through the DIBBS system by the revised deadline of July 14, 2026, at 3:00 PM ET, following a previous amendment extending the original due date. Proposals must be organized into two volumes: a non-price section with completed SF 1449 forms and trade agreements certifications, and a price section with U.S. dollar unit prices per bottle for base and all option years, excluding federal excise tax. Evaluation follows a Lowest Price Technically Acceptable (LPTA) model, requiring technically acceptable ratings for both past performance and compliance with all specifications; failure to meet either results in rejection. Contractors must enter into business-to-business agreements with DLA and VA Pharmaceutical Prime Vendors for delivery and payment terms, and payments will originate from those prime vendors, not the government. The government prohibits assignment of payment rights and denies claim status for disputes between the contractor and prime vendors. A 0.5% cost recovery fee must be embedded in pricing and paid via Cashlink

POSTED

DEADLINE

6505--Technegas Plus SystemThe Department of Veterans Affairs San Diego Healthcare System is seeking quotations for a medical-grade generator system and associated supplies to produce technetium 99m labeled carbon nanoparticle aerosol for high-resolution pulmonary ventilation imaging, under solicitation number 36C26226Q1042. This is a full and open competition among Federal Supply Schedule holders, structured as a firm-fixed-price contract with a base year and four optional one-year periods, totaling up to five years of performance. The primary requirement is for a Technegas Plus System or an equivalent system that meets specified salient physical and functional characteristics, along with three packs per year of the corresponding preparation kit for 50 patient sets. The contract also includes delivery, installation, and both supplemental online and on-site training. All items must be procured as brand name or equal, with no gray market or remanufactured products permitted; vendors must be an original equipment manufacturer or an authorized distributor with verifiable, signed authorization documentation on the manufacturer’s official letterhead. Shipping is FOB destination and must be included in the quoted unit cost. The solicitation adheres to FAR Subpart 8.4 and VAAR supplements, with the NAICS code 325412 and a small business size standard of 1,300 employees. All offerors must be registered in SAM.gov with active, accurate registrations; failure to provide proper OEM authorization documentation will result in a non-responsive offer. The VA explicitly excludes certain SAM representations from consideration, including affirmative action compliance and specific commercial services certifications, which will not impact award decisions. Questions must be submitted via email by July 7, 2026, at 10:00 a.m. Pacific Time, and responses to the solicitation are due by July 10, 2026, at the same time. Offerors are responsible for regularly monitoring SAM.gov for amendments and updates. All performance activities will occur at the VA San Diego Healthcare System located at 3350 La Jolla Village Drive, San Diego, CA 92161.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

LORATADINE TABLETSThe contract pertains to the procurement of LORATADINE TABLETS with the NSN/Part Number 6505-01-524-9179 and a requested quantity of one unit under Purchase Request 7014199416. The solicitation, identified as SPE2DP-26-T-3940, was posted on June 29, 2026, with a response deadline of July 6, 2026. This action is managed by the Defense Logistics Agency under the Department of Defense and is classified as a federal solicitation with no specific set-aside designation. The place of performance and office address details are not specified, and the point of contact information is unavailable. Interested parties must submit responses through the DIBBS portal via the provided UI link before the deadline to be considered for award.

Defense Logistics Agency

POSTED

2 days ago

DEADLINE

in 5 days

AI Contract Overview

Le Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec cherche à contracter un fournisseur unique pour la préparation en lot de seringues contenant l’antibiotique pipéracilline-tazobactam, à trois concentrations spécifiques : 2.25 g, 3.375 g et 4.5 g. Ce contrat d’approvisionnement est destiné à assurer la disponibilité de médicaments prêts à l’emploi pour les besoins cliniques au sein du réseau de santé, en garantissant des normes de stérilité, de précision et de traçabilité strictes. Les seringues préparées doivent répondre à des exigences pharmaceutiques élevées pour une utilisation sécuritaire dans un contexte hospitalier. La demande de soumission est publiée sous le numéro 20132277 avec une date de publication le 6 mai 2026 et une date limite de réponse fixée au 3 juin 2026 à 13 h 15. Le lieu de performance est situé dans les régions du Centre-du-Québec et de la Mauricie, et les soumissions doivent être adressées à la personne responsable des contrats, Marie-Claude Giguère, dont les coordonnées sont fournies pour toute question relative à l’appel d’offres. L’organisation, bien qu’identifiée comme un établissement de santé québécois, est classée sous le type d’organisation fédérale dans le cadre de la plateforme Canada Buys, et le processus est géré selon les procédures d’approvisionnement public du gouvernement canadien.

General Info

Contract for sterile pipericillin-tazobactam syringes in three concentrations for Quebec health network.

Agency

Government of Canada → Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec (CIUSSS MCQ)

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

Centre-du-Québec, Mauricie, CAN

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed

PostedMay 6

Solicitation

Response DeadlineJun 3

Deadline has passed

Submission Closed

06/03/2026, 01:15:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyGovernment of Canada → Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec (CIUSSS MCQ)

Contacts1 person available

OfficeN/A

Organization / Agency

Government of Canada → Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec (CIUSSS MCQ)

Office AddressN/A

Contacts

Giguère Marie-ClaudeContracting Authority

contact@example.gov

+1 (555) 000-0000

Full Description

Le CIUSSS de la Mauricie-et-du-Centre-du Québec désire obtenir le service de préparation de seringues de pipéracilline-tazobactam (antibiotique) à teneur de 2.25g, 3.375g et 4.5g. Le contrat est sous forme de contrat d'approvisionnement octroyé à un seul fournisseur.